Comments on: 2018 AAO Retina Subday: Simultaneous Inhibition of VEGF and Ang-2 with Genentech’s Faricimab in Neovascular AMD: STAIRWAY Phase 2 Results https://retinaroundup.com/2018/10/30/2018-aao-retina-subday-simultaneous-inhibition-of-vegf-and-ang-2-with-genentechs-faricimab-in-neovascular-amd-stairway-phase-2-results/ Tue, 30 Oct 2018 14:49:00 +0000 hourly 1